Innerwell combines personalized guidance from licensed therapists with cutting-edge psychedelic medicine. Now serving patients in Arizona, California, Colorado, Connecticut, Florida, New Jersey, New York, Ohio, Oregon, Utah, Texas, Virginia, Minnesota and Washington State. || Innerwell Reflections

Innerwell Reflections

Reflections

Find a Clinician by State

Find a Psychiatrist

Find a Therapist

Find Ketamine Treatment

Find EMDR Therapy

EMDR

Ketamine Treatment

Psychedelic Integration

psychiatry

therapy

mental-health

arizona-mental-health

california-mental-health

colorado-mental-health

connecticut-mental-health

Delaware

florida-mental-health

georgia-mental-health

idaho-mental-health

illinois-mental-health

iowa-mental-health

Kentucky

maine-mental-health

massachusetts-mental-health

michigan-mental-health

minnesota-mental-health

montana-mental-health

Nebraska

nevada-mental-health

new-hampshire-mental-health

new-jersey-mental-health

new-york-mental-health

north-carolina-mental-health

ohio-mental-health

oregon-mental-health

pennsylvania-mental-health

tennessee-mental-health

texas-mental-health

utah-mental-health

vermont-mental-health

virginia-mental-health

washington-mental-health

wisconsin-mental-health

 Personalized Mental Health Support from Wyoming Specialists

About

Refer a Patient to Innerwell

Work With Us

Reviews

Why Innerwell

Contact

Affiliate Program

Ketamine for Depression

Ketamine for Anxiety

Ketamine for PTSD

Ketamine for Postpartum Depression

Welcome! What service are you primarily interested in?

Innerwell Privacy Policy

Terms & Conditions

Innerwell Telehealth and Informed Consent

Page Not found. It's okay, we all get a little lost from time to time. 

Find Therapy & Counseling Services Near Me

KBS, Inc. and its affiliates (“Innerwell”) provide a platform that connects medical professionals with individuals. Innerwell does not control or direct the activity of the medical professionals providing care through the platform. Innerwell does not provide medical advice and nothing on the platform should be considered medical advice.

The suspicious thoughts won't stop. Your loved one refuses to leave the house, convinced people are watching. Or maybe you're the one struggling to trust anyone, to feel safe in your own home. If you've tried standard treatments without relief, you're probably searching for alternatives.

Ketamine can help depression when nothing else works, and for good reason. Research shows it provides rapid relief when standard medications fail. But this doesn't apply to paranoia. The drug's mechanism actually worsens psychotic symptoms rather than helping them.

Here's what you need to know upfront: Ketamine therapy is not recommended for people experiencing paranoia or psychotic symptoms.

This guide explains why ketamine is inappropriate for paranoia, documents the specific safety risks from clinical research, and identifies evidence-based treatments that actually work. If you're caring for someone with paranoia, this article also addresses how Innerwell can support your own mental health as a caregiver.

Paranoia involves persistent, unfounded beliefs that others intend harm. It exists on a spectrum, from mild suspicious thoughts to severe delusional beliefs that disconnect a person from reality.

A substantial minority of the general public report experiencing some paranoid thoughts. The lifetime prevalence of persecutory delusions is estimated at around 5%. Paranoia ranges from common everyday suspiciousness to clinical conditions requiring psychiatric care.

Belief that people are plotting or conspiring

Difficulty confiding in others due to fear of betrayal

Reading threatening meanings into benign events

In severe cases, fixed delusional beliefs

Paranoia appears across multiple conditions. Recent research suggests paranoia is common among people with schizophrenia, though precise prevalence varies. Paranoid symptoms also occur in dementia, with delusions reported in around 10–12% of Alzheimer's patients.

Depression and anxiety frequently co-occur with paranoia. A 2023 meta-analysis found 60% combined prevalence of anxiety and mood disorders in people at clinical high risk for psychosis. The high rate of comorbid mood symptoms creates a clinical challenge we'll address later.

Why Is Ketamine NOT Recommended for Paranoia?

Ketamine poses genuine risks for people with paranoid symptoms. The concern isn't theoretical. It's based on how ketamine affects the brain and documented adverse outcomes.

Ketamine is classified as a dissociative anesthetic because it induces altered states of consciousness. At therapeutic doses, it can cause hallucinations, perceptual disturbances, and breaks from reality.

For someone already experiencing paranoid thoughts, introducing ketamine creates unacceptable risk. 1997 research found ketamine caused "exacerbation of core psychotic and cognitive symptoms in schizophrenia." The drug worsened both hallucinations and delusions. No clinical trials have studied ketamine for paranoia treatment, and patients with paranoid features are excluded from existing studies due to safety concerns.

Ketamine works by blocking NMDA receptors, brain switches that control learning and memory. In depression, this process may help repair damaged connections through neuroplasticity. But in people with paranoia, the same mechanism destabilizes circuits that help process reality.

Here's the problem: The "glutamate hypothesis of schizophrenia" proposes that NMDA receptor dysfunction causes psychotic symptoms. 2016 research confirms NMDA receptor hypofunction is believed to underlie schizophrenic psychosis. Ketamine blocks these same receptors. While this mechanism may help reset circuits involved in depression, it paradoxically destabilizes circuits that generate paranoia and other psychotic symptoms.

A 2020 review found ketamine induces schizophrenia-like symptoms with large effect sizes in healthy participants. Scientists use ketamine as a research model to understand how psychotic states develop. They use it to study psychosis, not treat it.

Published case reports reveal what happens when ketamine reaches vulnerable patients. A 2024 case report documented a 55-year-old with treatment-resistant depression on antipsychotic medication who developed acute psychotic symptoms 48 hours after esketamine administration. Another case documented prolonged psychosis with delusions and hallucinations following ketamine for pain control.

Major safety concern: Psychotic symptoms can emerge after ketamine treatment, sometimes 48 hours later despite concurrent antipsychotic medication. These symptoms can be prolonged and severe, requiring emergency psychiatric intervention.

What Treatments Actually Work for Paranoia?

For schizophrenia-related paranoia, standard antipsychotic medications help approximately two-thirds of patients. Treatment effectiveness varies by underlying condition.

Antipsychotic medications remain first-line treatment. Both first-generation (like haloperidol) and second-generation (like risperidone) antipsychotics are recommended by the American Psychiatric Association. However, approximately one-third of patients with schizophrenia are classified as treatment-resistant, characterized by persistent symptoms despite two or more medication trials at adequate doses.

While paranoid symptoms may improve with medication, negative and cognitive symptoms often show limited response. Individual response varies considerably.

For those who don't respond to initial treatments, several evidence-based alternatives exist:

Clozapine is specifically recommended by the APA for treatment-resistant schizophrenia. Research finds that 30–40% of treatment-resistant patients respond to clozapine. It requires regular blood monitoring but helps many who haven't responded to other medications.

Long-acting injectable antipsychotics improve medication consistency and significantly reduce relapse risk compared to daily pills.

Cognitive behavioral therapy for psychosis (CBTp) is strongly recommended by WHO and NICE guidelines for all adults with psychotic disorders. It helps patients examine beliefs, develop coping strategies, and reduce symptom-related distress.

Even when medications don't fully eliminate paranoid delusions, they often reduce intensity and distress.

Additional resources include NAMI (National Alliance on Mental Illness) at nami.org and the SAMHSA National Helpline at 1-800-662-4357.

What Conditions Can Ketamine Therapy Help With?

While ketamine isn't appropriate for paranoia, it works remarkably well for other treatment-resistant mental health conditions.

Ketamine therapy has shown strong results for:

Treatment-resistant depression: Response rates exceed 50%, with effects beginning within hours rather than weeks

Anxiety disorders: Ketamine targets different brain pathways than traditional medications

PTSD: Helps process traumatic memories when other treatments haven't worked

Borderline personality disorder: Supports emotional regulation and stability

If you have one of these conditions without paranoid symptoms and haven't found relief through standard care, ketamine therapy might offer the breakthrough you've been searching for.

Learn more about whether ketamine is right for you.

How Can Innerwell Support Your Mental Health Journey?

Innerwell provides at-home ketamine therapy for conditions where it's proven safe and effective, including treatment-resistant depression, anxiety disorders, and borderline personality disorder. Every potential patient undergoes comprehensive psychiatric evaluation to ensure safety and appropriateness.

Innerwell's eligibility criteria explicitly exclude patients with psychosis or psychotic disorders from ketamine treatment. This isn't a limitation; it's a commitment to your safety.

If you have a psychotic disorder, Innerwell still offers traditional psychiatry and therapy services that include:

Medication management with qualified psychiatric providers

Individual psychotherapy using evidence-based approaches

Ongoing clinical support through a secure patient portal

For caregivers: If you're caring for someone with paranoia and experiencing treatment-resistant depression or anxiety yourself (without psychotic symptoms), Innerwell's at-home therapy program may help you maintain the resilience you need. Treatment delivered to your home fits around caregiving responsibilities.

Take our free assessment to connect with Innerwell's clinical team about the right treatment path for your situation.

Frequently Asked Questions About Ketamine and Paranoia

Why isn't ketamine recommended for paranoia?

Ketamine blocks NMDA receptors, creating a brain state that mirrors the glutamate hypothesis of schizophrenia. Research shows it causes "exacerbation of core psychotic and cognitive symptoms" rather than improvement. No clinical trial evidence supports its use for paranoid conditions.

Why does ketamine help depression but worsen paranoia?

Depression and psychotic disorders involve different brain chemistry. Ketamine's NMDA blocking mechanism helps depression by promoting new neural connections. However, psychotic disorders involve dysregulated NMDA function where blocking these receptors worsens rather than improves symptoms.

What if my paranoia is mild or only occasional?

Even a history of paranoid thoughts should be disclosed to Innerwell's clinical team before considering ketamine. Full disclosure of any psychiatric history is essential for determining eligibility and ensuring your safety.

What should I try if standard treatments aren't working for paranoia?

Evidence-based alternatives include clozapine for treatment-resistant schizophrenia, CBTp, long-acting injectable antipsychotics, and comprehensive psychosocial services including family therapy and case management. Innerwell's psychiatric team can help you explore which options fit your situation.

Does Innerwell screen for paranoia before treatment?

Yes. All patients undergo comprehensive psychiatric evaluation. Patients with active psychosis or psychotic disorders are explicitly excluded from ketamine treatment eligibility.

 Ketamine therapy isn't suitable for paranoia. Learn why, what the risks are, and which evidence-based treatments actually work.

Ketamine Therapy for Paranoia: What You Need to Know

Introduction

What Is Paranoia?

It's 3am again. You've tried Ambien, then Lunesta, then trazodone. You've done the sleep hygiene, the CBT-I, the meditation apps. Your doctor says you've "tried everything."

You're not alone. About 60% of people who try CBT-I don't achieve complete remission, and roughly 11-58% of patients have persistent symptoms despite available treatments. So you lie awake scrolling through Reddit threads about ketamine for insomnia, wondering if this could finally help.

Here's what the research actually shows: No clinical trials have tested ketamine as a primary treatment for insomnia. The Reddit threads reflect a growing disconnect between online marketing and medical evidence.

Ketamine has shown promise for sleep symptoms among people with treatment-resistant depression. For those whose insomnia stems from underlying mood disorders, ketamine may offer relief by treating the root cause. All documented sleep improvements occurred in patients being treated for depression—not insomnia alone.

Ketamine isn't a sleep medication. If you have insomnia without significant depression or anxiety, it may not address your sleep problems directly. This guide explains who might benefit, what the research shows, and how to make an informed decision.

Chronic insomnia is more than occasional sleeplessness. It's a persistent condition involving difficulty falling asleep, staying asleep, or waking too early at least three nights per week for three months or longer. The consequences extend far beyond fatigue.

Research shows insomnia leads to productivity loss, including increased presenteeism and absenteeism. The financial burden is significant: moderate to severe cases show up to 72% higher lost workplace productivity costs compared to non-insomniacs.

You're far from alone. A 2024 meta-analysis found 852 million adults live with insomnia globally. CDC data shows 14.5% of adults had trouble falling asleep most days in 2020. Treatment-resistant patients have struggled for an average of 10 years, used prescription sleep medications for 4.5 years, and tried multiple medications without lasting success.

If you have both insomnia and depression or anxiety, you're experiencing one of the most common patterns in sleep medicine. About 40-50% of people with chronic insomnia meet diagnostic criteria for depression. For generalized anxiety disorder, the rate is 25-45%. The connection is even stronger in PTSD, where 80-90% report significant sleep disturbances.

If you have treatment-resistant insomnia, there's a strong likelihood an underlying mood disorder contributes to your sleep problems. Treating both conditions may work better than targeting sleep alone.

Traditional Treatments & Their Limitations

Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the gold standard first-line treatment. Studies show 70-80% of patients who complete 6-8 weekly sessions achieve therapeutic response. Effects persist for years.

The catch: only 40% achieve complete remission. If CBT-I didn't fully work for you, you're in the majority. That's not a personal failure.

FDA-approved medications include newer orexin antagonists: daridorexant (Quviviq), lemborexant (Dayvigo), and suvorexant (Belsomra). A recent meta-analysis found daridorexant and lemborexant among the most effective for sleep maintenance. Traditional options like Z-drugs and benzodiazepines help many people but carry documented limitations—dependence risk, tolerance development, next-day drowsiness, and incomplete relief.

Ketamine works differently than traditional antidepressants or sleep medications. Rather than targeting serotonin or inducing sedation, it blocks NMDA receptors in the brain. The blockade triggers a glutamate surge that activates pathways for forming new connections and producing growth factors like BDNF—a protein that helps repair damaged neural pathways.

BDNF increases correlate with antidepressant response in people with major depressive disorder. One study found BDNF increases also correlated with improvements in deep sleep slow waves. These findings haven't been demonstrated in people with primary insomnia. All evidence of ketamine's sleep effects comes from patients with comorbid mood disorders.

Ketamine appears to improve sleep through two pathways. First, according to Frontiers research, ketamine can acutely increase slow wave (deep) sleep activity and alter brain chemicals that affect sleep-wake regulation. It also decreases REM sleep duration and delays REM onset. The long-term implications of REM suppression aren't yet clear.

Second, ketamine reduces the depression, anxiety, and rumination that prevent good sleep. In patients with treatment-resistant depression, studies show significant improvements in insomnia symptoms, nighttime restlessness, and early morning waking. Sleep changes contribute to mood benefits.

If depression or anxiety disrupts your sleep, ketamine's mood benefits may restore healthier sleep patterns. If you have primary insomnia without significant mood symptoms, you'd be left with only the direct sleep effects—including REM suppression with unclear long-term implications.

Here's the critical finding: No published clinical trials have tested ketamine as a primary treatment for insomnia in otherwise healthy individuals.

The largest study, published in 2023, involved 323 patients receiving ketamine for treatment-resistant depression. Sleep improvements were statistically significant: insomnia symptoms, nighttime restlessness, and early morning waking all improved meaningfully. Separating direct from indirect effects remains challenging without targeted insomnia trials.

A 2024 study using objective sleep measurements in 36 depression patients found no significant effects on sleep architecture. The authors concluded larger samples may be needed to detect sleep effects.

All evidence consistently shows ketamine may help your sleep by addressing comorbid mood disorders. It hasn't been shown to treat insomnia independently of mood improvement.

What Are the Risks of Ketamine Therapy for Insomnia?

Ketamine carries specific risks for insomnia patients. These deserve serious consideration.

Paradoxical worsening: 2020 research shows 7.3% of patients develop new-onset insomnia during ketamine treatment. Your sleep could get worse.

Drug interactions: Benzodiazepines can reduce ketamine's antidepressant effects, especially at higher doses. Using strong sedatives concurrently warrants caution due to enhanced sedation, though most sleep medications aren't universally contraindicated.

Common side effects: Dissociation and perceptual disturbances, blood pressure increases, nausea, dizziness, and memory problems during and after treatment.

Abuse potential: Ketamine has documented abuse liability. Regulatory agencies recommend extra caution in people with a history of substance use.

Currently take benzodiazepines or Z-drugs for sleep

Have active psychosis or severe psychiatric instability

Have significant breathing problems or sleep apnea

The FDA issued warnings in 2023 about ketamine risks including respiratory depression and psychiatric events. Ketamine has no FDA approval for any sleep disorder.

How Innerwell's Ketamine Therapy Approach Works

If you have both treatment-resistant mood disorders and insomnia, ketamine may help your sleep as an indirect benefit. Innerwell provides an initial psychiatric evaluation to assess whether you're an appropriate candidate.

The process unfolds through several key phases:

Comprehensive clinical evaluation — Our psychiatric specialists assess your sleep patterns alongside mood symptoms. We screen for medication interactions and identify whether depression or anxiety may be driving your insomnia.

Secure at-home medication delivery — If prescribed, you receive ketamine with comprehensive clinician oversight through secure messaging. Our team screens for medication interactions.

Guided preparation and integration therapy — For people with comorbid mood and sleep disorders, integration focuses on rumination, sleep anxiety, and mood symptoms alongside sleep strategies. Our therapists help you develop sustainable approaches for both mood improvement and better sleep.

Ongoing monitoring and dosage adjustment — Your treatment team monitors your response, adjusting protocols based on both mood and sleep outcomes. Regular assessment ensures any adverse effects are caught early.

Sleep improvement may occur when treating comorbid psychiatric and sleep conditions. If you have both, we can honestly discuss whether addressing your mood disorder might help your sleep.

Is Ketamine Therapy for Insomnia Right for Me?

If you have both treatment-resistant mood disorders and insomnia, ketamine may offer relief by treating the root cause.

You have BOTH treatment-resistant depression or anxiety AND chronic insomnia

Your insomnia is driven by rumination, anxiety, or depressive symptoms

You haven't responded to at least two antidepressant treatments

You've completed an adequate trial of CBT-I without full relief

You're not currently taking benzodiazepines or Z-drugs

You have primary insomnia without significant depression or anxiety

You're seeking a sleep medication replacement

You meet any contraindications in the risks section

The ideal candidate understands that sleep improvement is an indirect benefit of treating the underlying mood disorder. Ketamine won't replace CBT-I or good sleep hygiene. It addresses the mood disorders that may be preventing those approaches from working.

Try Ketamine Therapy for Insomnia With Innerwell

If you have comorbid treatment-resistant depression and insomnia, ketamine therapy through Innerwell may help address both conditions. Our psychiatric specialists will evaluate whether you're an appropriate candidate and create a personalized treatment plan.

Take our free assessment to see if ketamine therapy might help.

No published clinical trials have tested ketamine as a primary treatment for insomnia. While a trial examining ketamine's effect on sleep quality has been registered, no results are available yet. All published evidence showing sleep improvements comes from people being treated for depression. Ketamine may help your sleep by treating a comorbid mood disorder, but it's not a direct insomnia treatment.

Can I take ketamine if I'm on sleep medications?

Taking ketamine alongside benzodiazepines or Z-drugs like Ambien creates safety risks outlined above. You may be able to use ketamine if these medications are first discontinued under medical supervision. Your clinical team will create a safe taper protocol before starting ketamine.

Yes. Research shows 7.3% of people develop new or worsened insomnia during ketamine treatment. Close monitoring during initial weeks helps catch any worsening early.

How long does it take for ketamine to improve sleep?

Timeline varies. In clinical studies, some people noticed mood improvement within 24 hours, with sleep benefits emerging over days to weeks as underlying depression improved. Sleep improvement generally follows mood improvement. Mood improvement is the primary therapeutic goal.

What if I don't have depression—just insomnia?

Ketamine may not be appropriate for primary insomnia without significant comorbid depression or anxiety. While ketamine does directly enhance deep sleep and alter sleep architecture, the clinical benefit in studied populations targets depression-related sleep disruption. Evidence-based alternatives include comprehensive CBT-I and newer orexin antagonists like daridorexant and lemborexant.

Ketamine isn't a sleep medication, but it may help insomnia driven by depression or anxiety. Learn about the research, risks, and Innerwell's approach.

Ketamine Therapy for Insomnia: Complete Guide

What Is Chronic Insomnia?

How Does Ketamine Therapy Work?

You've done the research. You know ketamine therapy might finally help your treatment-resistant depression when nothing else has. But now you're trying to figure out the practical details: How much ketamine will you actually receive? Is there a standard dose, or does it vary? What's the difference between IV infusions and at-home options?

The numbers can feel overwhelming: milligrams, kilograms, bioavailability percentages. And if you've read anything about ketamine outside medical contexts, you might worry about getting the dose wrong.

Here's what's reassuring: you don't calculate your own dose. Your clinician handles this based on established protocols and your individual response.

Your clinician determines your dose based on your body, your medical history, and how you respond to treatment. For treatment-resistant depression, IV protocols typically use 0.5 mg/kg while at-home sublingual programs use higher doses (adjusted for absorption differences). Either way, your care team calibrates and adjusts based on what works for you.

The doses used for depression are much lower than surgical anesthesia (roughly one-quarter the amount). This produces rapid antidepressant effects while you remain awake and alert. Clinical trials report significant symptom reduction from this carefully calibrated range.

Your clinician determines your ketamine dose based on your body and response. Learn how dosing works across IV, Spravato, and at-home sublingual options.

Reflections

Ketamine Therapy for Paranoia: What You Need to Know

Ketamine Therapy for Insomnia: Complete Guide

Ketamine Therapy Dosage Guide

How Ketamine Affects the Brain: Understanding the Science

Ketamine Therapy for Grief: Science, Safety & Hope

Ketamine Therapy for OCD: Complete Guide

12 Evidence-Based SSRI Alternatives for Depression Relief